Benjamin R. Cowen
Director/Board Member chez INCON CO.,LTD.
Postes actifs de Benjamin R. Cowen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INCON CO.,LTD. | Director/Board Member | - | - |
Atrin Pharmaceuticals LLC
 Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Director/Board Member | 01/01/2012 | - |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Chief Executive Officer | 01/11/2017 | - |
| President | - | - | |
| Chief Operating Officer | 01/01/2016 | 01/01/2017 |
Historique de carrière de Benjamin R. Cowen
Anciens postes connus de Benjamin R. Cowen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
Formation de Benjamin R. Cowen
| Carnegie Mellon University | Masters Business Admin |
| University of Illinois | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 2 |
| Corée du Sud | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Consumer Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| INCON CO.,LTD. | Consumer Durables |
| Entreprise privées | 2 |
|---|---|
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Health Technology |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
- Bourse
- Insiders
- Benjamin R. Cowen
- Expérience
